CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity is to support studies with a focus on developing drug delivery strategies that target the Central Nervous System (CNS) for better suppression of Human Immunodeficiency Virus (HIV) and reservoir reduction.  Applications are sought proposing multidisciplinary efforts to enhance delivery of antiretroviral (ARV) drugs and biologics into CNS compartments, maintaining a good balance between therapeutic effect and toxicity. Collaborative research partnerships are strongly encouraged but not required.

Deadlines:

  • Application Due Date(s): January 7, 2019; January 7, 2020; January 7, 2021
  • AIDS Application Due Date(s): January 7, 2019; January 7, 2020; January 7, 2021

PAR-18-895 Expiration Date January 8, 2021

Eligibility

Faculty

Category

Engineering and Physical Sciences
Interdisciplinary
Medical
Medical - Clinical Science
Medical - Translational

External Deadline

January 7, 2021